Research ArticleClinical Investigation
Imaging Neuroinflammation in Neurodegenerative Disorders
Joseph C. Masdeu, Belen Pascual and Masahiro Fujita
Journal of Nuclear Medicine June 2022, 63 (Supplement 1) 45S-52S; DOI: https://doi.org/10.2967/jnumed.121.263200
Joseph C. Masdeu
1Nantz National Alzheimer Center, Stanley H. Appel Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas; and
Belen Pascual
1Nantz National Alzheimer Center, Stanley H. Appel Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas; and
Masahiro Fujita
1Nantz National Alzheimer Center, Stanley H. Appel Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas; and
2PET Core, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue Supplement 1
June 1, 2022
Imaging Neuroinflammation in Neurodegenerative Disorders
Joseph C. Masdeu, Belen Pascual, Masahiro Fujita
Journal of Nuclear Medicine Jun 2022, 63 (Supplement 1) 45S-52S; DOI: 10.2967/jnumed.121.263200
Jump to section
- Article
- Abstract
- TSPO PET: CURRENT TARGET TO IMAGE NEUROINFLAMMATION
- NEUROINFLAMMATION PET IN NEURODEGENERATIVE DISORDERS
- LIMITATIONS OF TSPO PET
- NEW INFLAMMATION IMAGING TARGETS TO OVERCOME THE LIMITATIONS OF TSPO PET
- OTHER PET MARKERS TO STUDY NEUROINFLAMMATION
- LINKAGE BETWEEN PERIPHERAL AND CENTRAL INFLAMMATION
- DISCLOSURE
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics